Cite
HARVARD Citation
Wu, M. et al. (2021). Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability. Clinical science. 135 (14), pp. 1707-1726. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wu, M. et al. (2021). Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability. Clinical science. 135 (14), pp. 1707-1726. [Online].